Okayama, Japan

Koreyoshi Imamura

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Ajinomoto Co., Ltd., Okayama University. Active years: 2011.



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Koreyoshi Imamura: Innovator in Aminoacylase Technology

Introduction

Koreyoshi Imamura is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of aminoacylases. His work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Koreyoshi Imamura holds a patent for an invention titled "Nε-acyl-L-lysine-specific aminoacylase." This invention provides an aminoacylase that exhibits superior abilities in specifically acylating and hydrolyzing the e-amino group of Lys. The patent outlines a method for producing Nε-acyl-L-lysine, which involves acting the aminoacylase on L-Lys and a carboxylic acid. This innovation is significant for its potential applications in various biochemical processes.

Career Highlights

Throughout his career, Koreyoshi Imamura has worked with prestigious institutions, including Okayama University and Ajinomoto Co., Ltd. His experience in these organizations has allowed him to develop his expertise in aminoacylase technology and contribute to advancements in the field.

Collaborations

Koreyoshi Imamura has collaborated with notable colleagues such as Hiroyuki Imanaka and Mayuko Koreishi. These collaborations have further enriched his research and development efforts in biochemistry.

Conclusion

Koreyoshi Imamura is a distinguished inventor whose work in aminoacylase technology has the potential to impact various industries. His patent and collaborations reflect his commitment to advancing scientific knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…